⌘K

Login Start Free

Home/Filings/4/A/0000897069-25-000292

4/A//SEC Filing

Lin Patrick 4/A

Accession 0000897069-25-000292

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 5:54 PM ET

Size

8.7 KB

Accession

0000897069-25-000292

Insider Transaction Report

Form 4/AAmended

Period: 2025-02-17

Processa Pharmaceuticals, Inc.PCSA

Chief Business - Strategy Off

Transactions

Award
Warrants
2025-01-29+43,500→ 43,500 total(indirect: By Trust)
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (43,500 underlying)
Award
Warrants
2025-01-29+21,750→ 21,750 total(indirect: By Trust)
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (21,750 underlying)

Holdings

Common Stock
29,059
Common Stock
(indirect: By Trust)
43,500

Documents

1 file

4
form4.xml

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001799363

Filing Metadata

Form type: 4/A
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 5:54 PM ET
Size: 8.7 KB

View on SEC.gov